High glycemic variability is associated with a reduced T cell cytokine response to influenza A virus
- PMID: 39524368
- PMCID: PMC11550119
- DOI: 10.1016/j.isci.2024.111166
High glycemic variability is associated with a reduced T cell cytokine response to influenza A virus
Abstract
Diabetes mellitus significantly increases the risk of severe respiratory virus disease like influenza and COVID-19. Early evidence suggests that this susceptibility to respiratory viral disease is driven by glycemic variability, rather than average blood glucose levels. Here, we use blood samples and constant glucose monitoring (CGM) data obtained from people living with type 1 diabetes (T1D) to determine the effects of glycemic variability on the ex vivo T cell response to influenza virus. We show that high glycemic variability in participants living with T1D is associated with a reduced proportion of CD8+CD107a-IFNγ-MIP1β-TNF+ T cells in response to stimulation with influenza virus and an influenza virus peptide pool. Thus, this study provides evidence that glycemic variability affects the ex vivo T cell response to respiratory viruses. These data suggest that monitoring glycemic variability may have important implications in understanding the antiviral immune response in people with diabetes.
Keywords: Endocrinology; Human metabolism.
© 2024 The Author(s).
Conflict of interest statement
The authors declare no competing interest.
Figures



Similar articles
-
Glycemic Variability in Diabetes Increases the Severity of Influenza.mBio. 2020 Mar 24;11(2):e02841-19. doi: 10.1128/mBio.02841-19. mBio. 2020. PMID: 32209691 Free PMC article.
-
Increasing HbA1c is associated with reduced CD8+ T cell functionality in response to influenza virus in a TCR-dependent manner in individuals with diabetes mellitus.Cell Mol Life Sci. 2024 Jan 12;81(1):35. doi: 10.1007/s00018-023-05010-4. Cell Mol Life Sci. 2024. PMID: 38214784 Free PMC article.
-
Glycemic variability and indices of glycemic control among pregnant women with type 1 diabetes (T1D) based on the use of continuous glucose monitoring share technology.J Matern Fetal Neonatal Med. 2022 Dec;35(25):8968-8974. doi: 10.1080/14767058.2021.2008895. Epub 2021 Dec 7. J Matern Fetal Neonatal Med. 2022. PMID: 34875947
-
Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review.Adv Ther. 2024 Sep;41(9):3471-3488. doi: 10.1007/s12325-024-02943-5. Epub 2024 Aug 2. Adv Ther. 2024. PMID: 39093492 Free PMC article. Review.
-
Diabetes technology and treatments in the paediatric age group.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Int J Clin Pract Suppl. 2011. PMID: 21323816 Review.
Cited by
-
Memory T Cells in Respiratory Virus Infections: Protective Potential and Persistent Vulnerabilities.Med Sci (Basel). 2025 Apr 29;13(2):48. doi: 10.3390/medsci13020048. Med Sci (Basel). 2025. PMID: 40407543 Free PMC article. Review.
References
-
- Longmore D.K., Miller J.E., Bekkering S., Saner C., Mifsud E., Zhu Y., Saffery R., Nichol A., Colditz G., Short K.R., et al. Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis. Diabetes Care. 2021;44:1281–1290. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials